Johnson Matthey PLC (LON:JMAT - Get Free Report) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,454.36 ($19.53) and traded as high as GBX 1,870 ($25.11). Johnson Matthey shares last traded at GBX 1,865 ($25.04), with a volume of 438,564 shares changing hands.
Johnson Matthey Price Performance
The stock has a market capitalization of £3.11 billion, a P/E ratio of 31.62, a PEG ratio of 49,242.50 and a beta of 0.95. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73. The company has a 50 day moving average of GBX 1,644.58 and a 200-day moving average of GBX 1,455.93.
Johnson Matthey (LON:JMAT - Get Free Report) last released its quarterly earnings data on Thursday, May 22nd. The company reported GBX 149.20 ($2.00) EPS for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. Sell-side analysts predict that Johnson Matthey PLC will post 173.4112903 EPS for the current year.
Insider Buying and Selling at Johnson Matthey
In other Johnson Matthey news, insider Liam Condon bought 30 shares of the business's stock in a transaction dated Wednesday, April 16th. The shares were purchased at an average price of GBX 1,200 ($16.11) per share, with a total value of £360 ($483.35). In the last 90 days, insiders purchased 62 shares of company stock valued at $84,978. 0.61% of the stock is currently owned by company insiders.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Featured Stories
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
